FR2454099A1 - Methode de detection du cancer - Google Patents

Methode de detection du cancer

Info

Publication number
FR2454099A1
FR2454099A1 FR8007691A FR8007691A FR2454099A1 FR 2454099 A1 FR2454099 A1 FR 2454099A1 FR 8007691 A FR8007691 A FR 8007691A FR 8007691 A FR8007691 A FR 8007691A FR 2454099 A1 FR2454099 A1 FR 2454099A1
Authority
FR
France
Prior art keywords
cancer
detection method
cancer detection
concentration
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8007691A
Other languages
English (en)
French (fr)
Other versions
FR2454099B1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2454099A1 publication Critical patent/FR2454099A1/fr
Application granted granted Critical
Publication of FR2454099B1 publication Critical patent/FR2454099B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Sink And Installation For Waste Water (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR8007691A 1979-04-10 1980-04-04 Methode de detection du cancer Granted FR2454099A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (2)

Publication Number Publication Date
FR2454099A1 true FR2454099A1 (fr) 1980-11-07
FR2454099B1 FR2454099B1 (es) 1984-01-27

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8007691A Granted FR2454099A1 (fr) 1979-04-10 1980-04-04 Methode de detection du cancer

Country Status (24)

Country Link
JP (1) JPS55143441A (es)
KR (1) KR830002502A (es)
AR (1) AR222700A1 (es)
AT (1) AT365343B (es)
AU (1) AU536522B2 (es)
BE (1) BE882669A (es)
CH (1) CH644453A5 (es)
DE (1) DE3013837A1 (es)
DK (1) DK149980A (es)
ES (1) ES490396A0 (es)
FI (1) FI801078A (es)
FR (1) FR2454099A1 (es)
GB (1) GB2047712B (es)
GR (1) GR67692B (es)
HU (1) HU183122B (es)
IE (1) IE49981B1 (es)
IL (1) IL59772A (es)
IT (1) IT1143135B (es)
LU (1) LU82345A1 (es)
NL (1) NL8002094A (es)
NO (1) NO801018L (es)
PH (1) PH15637A (es)
SE (1) SE8002602L (es)
ZA (1) ZA802141B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000176A1 (en) * 1985-07-10 1987-01-15 Heyl Chemisch-Pharmazeutische Fabrik Gmbh + Co. Kg Unduline and its fragmentation products, production process and utilization thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol,91, no.17, 22 octobre 1979, page 474, résumé no. 138611k, COLUMBUS, Ohio (US) *
CHEMICAL ABSTRACTS, vol.86, no.9, 28 février 1977, page 133, résumé no. 51790r, COLUMBUS, Ohio (US) *
CHEMICAL ABSTRACTS, vol.89, no.17, 23 octobre 1978, page 436, résumé no. 144737f, COLUMBUS, Ohio (US) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000176A1 (en) * 1985-07-10 1987-01-15 Heyl Chemisch-Pharmazeutische Fabrik Gmbh + Co. Kg Unduline and its fragmentation products, production process and utilization thereof

Also Published As

Publication number Publication date
AU536522B2 (en) 1984-05-10
AU5719380A (en) 1980-10-16
GB2047712B (en) 1983-02-23
FR2454099B1 (es) 1984-01-27
HU183122B (en) 1984-04-28
IE800693L (en) 1980-10-10
NL8002094A (nl) 1980-10-14
DK149980A (da) 1980-10-11
FI801078A (fi) 1980-10-11
GB2047712A (en) 1980-12-03
DE3013837A1 (de) 1980-10-30
ZA802141B (en) 1981-04-29
SE8002602L (sv) 1980-12-09
ES8103380A1 (es) 1981-02-16
ATA195780A (de) 1981-05-15
AT365343B (de) 1982-01-11
IT1143135B (it) 1986-10-22
NO801018L (no) 1980-10-13
ES490396A0 (es) 1981-02-16
IT8048370A0 (it) 1980-04-09
KR830002502A (ko) 1983-05-30
GR67692B (es) 1981-09-07
IE49981B1 (en) 1986-01-22
IL59772A (en) 1983-05-15
AR222700A1 (es) 1981-06-15
PH15637A (en) 1983-03-11
IL59772A0 (en) 1980-06-30
JPS55143441A (en) 1980-11-08
BE882669A (fr) 1980-10-06
CH644453A5 (fr) 1984-07-31
LU82345A1 (fr) 1980-12-16

Similar Documents

Publication Publication Date Title
EP0804074A4 (en) TREATING SOLUTIONS OF RED BLOOD CELLS WITH ANTIVIRAL ACTIVE INGREDIENTS
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
HUP9901856A2 (hu) Eljárások és készítmények nukleinsavmolekulák vizsgálatára méret szerinti elválasztási technikák alkalmazásával
EP1870466A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
FR2447966A1 (fr) Conjugues analogue de ligand-inhibiteur enzymatique irreversible et procedes pour la determination des ligands les utilisant
HUP9903378A2 (hu) Az autoimmun betegségek immunterápiájában felhasználható autoantigének és ezekkel szerkezetileg rokon fehérjék
Hautzer et al. “Primary” spinal intramedullary lymphomas: a review
FR2449895A1 (fr) Determination d'iso-enzymes de creatine kinase au moyen de complexes anticorps-isoenzyme immobilises
EP1408333A3 (en) Diagnosis and treatment of Alzheimer's disease
AU2392692A (en) Method and kit for measuring endogenous cytokines
ATE242484T1 (de) Verfahren zur untersuchung von nierenkrankheiten
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
Sharma Experiments and techniques in biochemistry
FR2454099A1 (fr) Methode de detection du cancer
HUP0101285A2 (hu) Eljárások és készítmények a hepatóma diagnosztizálására
FR2435039A1 (fr) Composition pour determiner la microglobuline-b2 humaine, procede pour sa preparation et son emploi
ATE108906T1 (de) Methode zur bestimmung des verhaltens von medikamenten in lebewesen.
Yaegaki et al. Influence of aging on DNase activity in human parotid saliva
WO2001069261A3 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
RU2193780C1 (ru) Способ определения эндогенной интоксикации
KR102505221B1 (ko) 한국형 살무사과 사독 감별용 조성물
ØDUM et al. Electrophoretic investigations of acid-stable proteinase-inhibitory activity in human serum
SU1532877A1 (ru) Способ количественного определени полипептидных компонентов средней молекул рной массы в крови
SU1247014A1 (ru) Способ диагностики болезни Вильсона-Коновалова
SE8701437D0 (sv) Diagnostiskt forfarande in vitro samt medel som kan utnyttjas vid forfarandet

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse